Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

MRKR

Marker Therapeutics (MRKR)

Marker Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MRKR
DateTimeSourceHeadlineSymbolCompany
11/13/20204:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MRKRMarker Therapeutics Inc
11/09/20204:20PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MRKRMarker Therapeutics Inc
11/09/20204:09PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MRKRMarker Therapeutics Inc
11/09/20204:01PMPR Newswire (US)Marker Therapeutics Reports Third Quarter 2020 Operating and Financial ResultsNASDAQ:MRKRMarker Therapeutics Inc
11/02/20207:00AMPR Newswire (US)Marker Therapeutics to Host Third Quarter 2020 Operating and Financial Results Conference Call and Webcast on Monday, Novembe...NASDAQ:MRKRMarker Therapeutics Inc
09/17/20207:00AMPR Newswire (US)Marker Therapeutics to Present at the Virtual Oppenheimer Fall Healthcare Life Sciences & MedTech SummitNASDAQ:MRKRMarker Therapeutics Inc
08/10/20204:30PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MRKRMarker Therapeutics Inc
08/10/20204:04PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MRKRMarker Therapeutics Inc
08/10/20204:00PMPR Newswire (US)Marker Therapeutics Reports Second Quarter 2020 Operating and Financial ResultsNASDAQ:MRKRMarker Therapeutics Inc
06/30/20207:00AMPR Newswire (US)Marker Therapeutics Announces New Manufacturing Facility to Support Clinical Development of MultiTAA-Specific T Cell Therapy ...NASDAQ:MRKRMarker Therapeutics Inc
06/23/20208:52AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MRKRMarker Therapeutics Inc
06/23/20207:00AMPR Newswire (US)Marker Therapeutics Receives USAN Approval for "zelenoleucel" as Nonproprietary Name for MT-401, Multi-Tumor-Associated Antig...NASDAQ:MRKRMarker Therapeutics Inc
06/19/20207:50AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MRKRMarker Therapeutics Inc
06/18/20204:43PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MRKRMarker Therapeutics Inc
06/12/20204:17PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:MRKRMarker Therapeutics Inc
06/01/20209:24AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MRKRMarker Therapeutics Inc
05/29/20208:18AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MRKRMarker Therapeutics Inc
05/29/20208:00AMPR Newswire (US)Marker Therapeutics Reports Interim Results of its MultiTAA-Specific T Cell Therapy in Patients with Pancreatic Adenocarcinom...NASDAQ:MRKRMarker Therapeutics Inc
05/21/20204:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MRKRMarker Therapeutics Inc
05/13/20205:01PMPR Newswire (US)­­­­­­­­­Marker Therapeutics to Report Updated Results from Phase 1/2 Trial with MultiTAA-Specific T Cell Therapy in...NASDAQ:MRKRMarker Therapeutics Inc
05/11/20204:19PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MRKRMarker Therapeutics Inc
05/11/20204:05PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MRKRMarker Therapeutics Inc
05/11/20204:05PMPR Newswire (US)Marker Therapeutics Reports First Quarter 2020 Operating and Financial ResultsNASDAQ:MRKRMarker Therapeutics Inc
05/04/20204:05PMPR Newswire (US)Marker Therapeutics to Host First Quarter 2020 Operating and Financial Results Conference Call and Webcast on Monday, May 11,...NASDAQ:MRKRMarker Therapeutics Inc
04/29/20204:21PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MRKRMarker Therapeutics Inc
04/29/20204:05PMPR Newswire (US)Marker Therapeutics Receives FDA Orphan Drug Designation for its Multi-Antigen Targeted T Cell Therapy for Acute Myeloid Leuk...NASDAQ:MRKRMarker Therapeutics Inc
04/17/20204:02PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:MRKRMarker Therapeutics Inc
03/12/20204:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MRKRMarker Therapeutics Inc
03/12/20204:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MRKRMarker Therapeutics Inc
03/12/20204:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MRKRMarker Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MRKR

Your Recent History

Delayed Upgrade Clock